Experimental administration of SCFAs slows colonic transit in mice, suggesting new targets for gastrointestinal health.
Acutely, luminal administration of SCFAs activates myenteric neurons and slows colonic transit through FFAR2 and FFAR3 receptors.
No takes yet. Share an insight, caveat, or question.
Wongkrasant et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: